Molina Healthcare (MOH) Price Target Lowered to $94.00 at Morgan Stanley

Molina Healthcare (NYSE:MOH) had its price objective reduced by investment analysts at Morgan Stanley from $97.00 to $94.00 in a research report issued to clients and investors on Wednesday. The brokerage presently has an “overweight” rating on the stock. Morgan Stanley’s target price suggests a potential upside of 13.05% from the stock’s current price.

Other analysts have also issued research reports about the company. Zacks Investment Research upgraded Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $88.00 price target on the stock in a report on Tuesday, January 2nd. ValuEngine upgraded Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Thursday, November 9th. Goldman Sachs Group began coverage on Molina Healthcare in a research report on Wednesday, January 3rd. They issued a “neutral” rating and a $83.00 price objective for the company. JPMorgan Chase & Co. upgraded Molina Healthcare from a “neutral” rating to an “overweight” rating in a research report on Tuesday, January 16th. Finally, Raymond James Financial restated a “hold” rating on shares of Molina Healthcare in a research report on Friday, December 8th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. Molina Healthcare currently has a consensus rating of “Hold” and a consensus price target of $71.21.

Shares of Molina Healthcare (MOH) traded up $0.72 during mid-day trading on Wednesday, hitting $83.15. 496,138 shares of the stock traded hands, compared to its average volume of 1,323,005. The stock has a market capitalization of $5,228.27, a P/E ratio of -13.64, a P/E/G ratio of 1.02 and a beta of 1.10. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.29 and a current ratio of 1.29. Molina Healthcare has a 52 week low of $42.56 and a 52 week high of $93.98.

In other news, insider William Dentino sold 67,500 shares of Molina Healthcare stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $77.15, for a total value of $5,207,625.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Garrey Carruthers sold 1,300 shares of Molina Healthcare stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $75.66, for a total value of $98,358.00. Following the completion of the sale, the director now directly owns 7,016 shares in the company, valued at $530,830.56. The disclosure for this sale can be found here. Insiders sold 777,955 shares of company stock worth $61,729,330 over the last ninety days. Corporate insiders own 6.20% of the company’s stock.

Several large investors have recently modified their holdings of the company. Zions Bancorporation bought a new position in Molina Healthcare during the third quarter worth about $118,000. Tiedemann Wealth Management LLC raised its stake in shares of Molina Healthcare by 7.8% during the third quarter. Tiedemann Wealth Management LLC now owns 1,440,066 shares of the company’s stock worth $135,000 after acquiring an additional 103,775 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Molina Healthcare by 40.3% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,404 shares of the company’s stock worth $184,000 after acquiring an additional 690 shares in the last quarter. Sabal Trust CO purchased a new position in shares of Molina Healthcare during the third quarter worth approximately $206,000. Finally, First Quadrant L P CA raised its stake in shares of Molina Healthcare by 1,030.6% during the third quarter. First Quadrant L P CA now owns 3,618 shares of the company’s stock worth $249,000 after acquiring an additional 3,298 shares in the last quarter. 96.22% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: This article was reported by American Banking News and is the property of of American Banking News. If you are viewing this article on another publication, it was stolen and republished in violation of US and international copyright legislation. The legal version of this article can be viewed at https://www.americanbankingnews.com/2018/02/07/molina-healthcare-moh-price-target-lowered-to-94-00-at-morgan-stanley.html.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply